Ravens’ Medical Check Turns Trade on Its Head

The Baltimore Ravens pulled back a deal that had moved defensive lineman Maxx Crosby from the Las Vegas Raiders, citing concerns raised during a medical evaluation. The trade had been announced earlier in the week, with Baltimore offering first‑round draft picks for 2026 and 2027. But a second look at Crosby’s health record caused the Ravens to reverse course.

Crosby had recently undergone surgery for a meniscus tear in January, and the Raiders had asked him to sit out the final two games of the season. He left the team in frustration, and the trade seemed to offer him a fresh start. Yet when Baltimore’s doctors reviewed his file, they flagged lingering issues that made the player’s availability uncertain.

This isn’t an isolated case. In 2006, the Miami Dolphins hesitated to sign Drew Brees because of shoulder concerns, even though the player later proved healthy. In other sports, teams have scrapped deals over injuries: a Lakers trade fell apart because of a foot problem, and a baseball contract was voided after an old injury came to light. The NFL has seen similar reversals with players like Ryan Grant and Michael Brockers.

The decision highlights how medical staff can wield significant influence over roster moves. Team doctors often adopt a cautious stance, preferring to err on the side of safety rather than risk a player’s long‑term health. This conservative approach can protect a franchise but also creates uncertainty for players and other teams looking to acquire talent.

For the Raiders, the setback means they must decide how to move forward with Crosby. They could look for another trade partner or adjust their expectations of his performance in the upcoming seasons. Meanwhile, Baltimore has turned its attention to other prospects, such as edge rusher Trey Hendrickson, demonstrating that a single medical finding can reshape a team’s entire strategy.